National Perox.

Has National Perox. declared dividend?

Yes, National Peroxide Ltd has declared a 125% dividend, amounting to ₹12.5 per share, with an ex-date of August 20, 2024. However, the company's total returns have been negative in the last 6 months and stagnant over the past several years.

National Peroxide Ltd has declared a 125% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 125%<BR>- Amount per share: 12.5<BR>- Ex-date: 20 Aug 24<BR><BR>Dividend Yield: 2.05%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -30.82%, the dividend return was 0%, resulting in a total return of -30.82%.<BR><BR>Over the past year, there was no price return, no dividend return, leading to a total return of 0.0%.<BR><BR>In the 2-year period, the price return remained at 0%, with no dividend return, resulting in a total return of 0.0%.<BR><BR>For the 3-year period, the price return was 0%, with no dividend return, resulting in a total return of 0.0%.<BR><BR>In the 4-year period, there was a price return of 0%, no dividend return, leading to a total return of 0.0%.<BR><BR>Finally, in the 5-year period, the price return was 0%, with no dividend return, resulting in a total return of 0.0%.<BR><BR>Overall, while National Peroxide Ltd has declared a significant dividend, the total returns over various periods indicate a challenging performance, particularly in the short term with a notable decline in price return.

Is National Perox. overvalued or undervalued?

As of May 7, 2025, National Perox. is considered overvalued and risky, with a PE ratio of -157.63 and negative EV ratios, indicating poor financial performance compared to peers like Solar Industries and Godrej Industries, despite a recent stock return of 8.61%.

As of 7 May 2025, the valuation grade for National Perox. has moved from attractive to risky, indicating a significant shift in its financial outlook. The company is currently considered overvalued. Key ratios highlight this concern: the PE ratio stands at an alarming -157.63, while the EV to EBIT ratio is also negative at -64.72, and the EV to EBITDA ratio is at 20.91. These figures suggest that the company is struggling to generate profits relative to its valuation.<BR><BR>In comparison to its peers, National Perox. shows stark contrasts. For instance, Solar Industries India Ltd. has a PE ratio of 123.77, while Godrej Industries Ltd. boasts a PE ratio of 46.63, both indicating much stronger valuations. Additionally, National Perox.'s ROE is at -0.63%, further emphasizing its underperformance relative to the industry. Despite a recent stock return of 8.61% over the past week, which outperformed the Sensex's 1.35%, the overall financial metrics suggest that investors should approach National Perox. with caution.

What is the technical trend for National Perox.?

As of June 6, 2025, National Perox's technical trend has shifted to a moderate bearish stance, indicated by daily moving averages and weekly KST readings, despite some mixed signals from the Dow Theory and weekly MACD.

As of 6 June 2025, the technical trend for National Perox has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators include the daily moving averages showing a mildly bearish trend, while the weekly KST is bearish. The Dow Theory indicates a mildly bullish stance on the weekly but remains bearish on the monthly, suggesting mixed signals. The MACD on the weekly is mildly bullish, but the overall sentiment leans bearish due to the prevailing moving averages and KST readings.

Who are the peers of the National Perox.?

Peers of National Perox. include Primo Chemicals, Vikram Thermo, Mangalam Organic, Andhra Petrochem, Lords Chloro, Kanoria Chem., Alufluoride, Kesar Petroprod., and Hind.Organ.Chem. National Perox. has an average management risk and a 1-year return of -48.53%, higher than Andhra Petrochem's -52.23% but lower than Kesar Petroprod.'s 59.06%.

Peers: The peers of National Perox. are Primo Chemicals, Vikram Thermo, Mangalam Organic, Andhra Petrochem, Lords Chloro, Kanoria Chem., Alufluoride, Kesar Petroprod., and Hind.Organ.Chem.<BR><BR>Quality Snapshot: Excellent management risk is observed at Vikram Thermo and Alufluoride, while Average management risk is found at Primo Chemicals, Mangalam Organic, Andhra Petrochem, Lords Chloro, National Perox., Kesar Petroprod., and Sadhana Nitro, and Below Average management risk is noted at Kanoria Chem. and Hind.Organ.Chem. Growth is rated as Excellent for Alufluoride, Good for Vikram Thermo and Kesar Petroprod., Average for Primo Chemicals, Mangalam Organic, Andhra Petrochem, Lords Chloro, National Perox., and Sadhana Nitro, and Below Average for Kanoria Chem. and Hind.Organ.Chem. Capital Structure is Excellent for Andhra Petrochem, Good for National Perox. and Alufluoride, Average for Primo Chemicals, Mangalam Organic, Lords Chloro, and Kesar Petroprod., and Below Average for Kanoria Chem. and Hind.Organ.Chem.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Kesar Petroprod. at 59.06%, while the lowest is Andhra Petrochem at -52.23%. National Perox.'s own 1-year return is -48.53%, which is higher than Andhra Petrochem's but lower than Kesar Petroprod.'s. Additionally, the peers with negative six-month returns include Primo Chemicals, Andhra Petrochem, Kanoria Chem., Alufluoride, and Hind.Organ.Chem.

What does National Perox. do?

National Peroxide Ltd is a micro-cap company in the commodity chemicals industry, reporting net sales of 737 Cr and a net loss of 65 Cr for the quarter ending March 2025. The company has a market cap of INR 407 Cr and a dividend yield of 1.81%.

Overview:<BR>National Peroxide Ltd operates in the commodity chemicals industry and is classified as a micro-cap company.<BR><BR>History:<BR>The company was incorporated in 2020 as NPL Chemicals Limited and later changed its name to National Peroxide Limited following a Composite Scheme of Arrangement. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 737 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -65 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 407 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: N/A <BR>Industry P/E: 47 <BR>Dividend Yield: 1.81% <BR>Debt-Equity: -0.10 <BR>Return on Equity: -0.63% <BR>Price to Book: 1.11<BR><BR>Contact Details:<BR>No Company Details Available <BR>Registrar Address: Not available.

Who are the top shareholders of the National Perox.?

The top shareholders of National Perox include Nowrosjee Wadia And Sons Limited with 30.78% and individual investors with 24.82%. There are no mutual funds or foreign institutional investors holding shares in the company.

The top shareholders of National Perox include the promoters, with Nowrosjee Wadia And Sons Limited holding the largest stake at 30.78%. Additionally, individual investors collectively hold 24.82% of the shares. There are currently no mutual funds or foreign institutional investors (FIIs) holding shares in the company.

How big is National Perox.?

As of 24th July, National Peroxide Ltd has a market capitalization of 397.00 Cr and reported net sales of 286.87 Cr with a net loss of 2.25 Cr over the latest four quarters. Shareholder's funds are valued at 358.96 Cr, with total assets of 459.33 Cr as of March 2024.

As of 24th July, <BR><BR>Market Cap: National Peroxide Ltd has a market capitalization of 397.00 Cr, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 286.87 Cr, while the sum of Net Profit for the same period reflects a loss of 2.25 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the balance sheet is March 2024. Shareholder's Funds are valued at 358.96 Cr, and Total Assets amount to 459.33 Cr.

When is the next results date for National Perox.?

The next results date for National Perox. is 29 July 2025.

The next results date for National Perox. is scheduled for 29 July 2025.

How has been the historical performance of National Perox.?

National Perox has experienced a significant decline in financial performance over the past three years, with net sales dropping from 375.87 Cr in March 2023 to 286.87 Cr in March 2025, resulting in a loss of -2.25 Cr in profit after tax. Key metrics such as operating profit and earnings per share also fell sharply, indicating reduced profitability and cash generation capabilities.

Answer:<BR>The historical performance of National Perox shows a decline in key financial metrics over the past three years, culminating in a loss for the year ending March 2025.<BR><BR>Breakdown:<BR>National Perox's net sales decreased from 375.87 Cr in March 2023 to 286.87 Cr in March 2025, reflecting a downward trend in total operating income, which also fell from 375.87 Cr to 286.87 Cr during the same period. The company's total expenditure, excluding depreciation, decreased from 317.36 Cr in March 2023 to 271.66 Cr in March 2025, primarily due to a reduction in raw material costs from 191.26 Cr to 145.46 Cr. However, operating profit (PBDIT) declined significantly from 67.36 Cr in March 2023 to 19.70 Cr in March 2025, leading to a profit before tax of -2.08 Cr in March 2025, down from 53.50 Cr in March 2023. Consequently, profit after tax also turned negative, reaching -2.25 Cr in March 2025 compared to 39.50 Cr in March 2023. The company's earnings per share (EPS) reflected this downturn, dropping from 68.7 in March 2023 to -3.91 in March 2025. On the balance sheet, total liabilities decreased from 453.55 Cr in March 2023 to 441.72 Cr in March 2025, while total assets also fell from 453.55 Cr to 441.72 Cr. Cash flow from operating activities showed a decline from 67.00 Cr in March 2023 to 18.00 Cr in March 2025, indicating a significant reduction in cash generation capabilities. Overall, National Perox's financial performance has deteriorated over the past three years, resulting in losses and reduced profitability.

Are National Perox. latest results good or bad?

National Peroxide's latest Q2 FY26 results are concerning, showing a 56.18% decline in net profit and an 11.33% drop in revenue year-on-year, despite a slight quarter-over-quarter revenue increase. The significant decrease in operating margins indicates ongoing financial struggles, characterizing the results as bad.

National Peroxide's latest results for Q2 FY26 indicate a challenging financial situation for the company. The net profit for the quarter was ₹0.39 crores, which represents a significant decline of 56.18% compared to the previous quarter and a 42.65% drop year-on-year. This decline in profitability raises concerns about the company's ability to sustain its operations effectively.<BR><BR>On the revenue front, the company reported ₹68.29 crores, marking a modest increase of 2.45% from the previous quarter. However, this figure is still 11.33% lower than the same quarter last year, continuing a trend of declining sales over recent years. The operating margin has also come under pressure, falling to 6.59%, down from 13.81% in Q2 FY24, indicating significant operational stress.<BR><BR>Overall, the financial performance reflects ongoing struggles, with deteriorating profit margins and a concerning reliance on non-operating income to maintain profitability. Given these factors, the results can be characterized as bad, highlighting the need for strategic changes to improve the company's financial health moving forward.

Should I buy, sell or hold National Perox.?

Which are the latest news on National Perox.?

Why is National Peroxide Ltd falling/rising?

As of 19-Jan, National Peroxide Ltd's stock price is at Rs 418.50, down 3.97%, and has reached a 52-week low of Rs 412.1. The stock has declined 10.58% year-to-date and 45.17% over the past year, reflecting weak fundamentals and a bearish trend.

As of 19-Jan, National Peroxide Ltd's stock price is falling, currently at Rs 418.50, reflecting a decrease of Rs 17.3 or 3.97%. The stock has been on a downward trend, having lost 4.85% over the last two days and underperformed its sector by 3.49% today. Additionally, it reached a new 52-week low of Rs 412.1, indicating significant selling pressure.<BR><BR>The stock has shown poor performance over various time frames, with a year-to-date decline of 10.58% and a staggering 45.17% drop over the past year. This decline is compounded by weak long-term fundamentals, including a -135.58% compound annual growth rate (CAGR) in operating profits over the last five years and a low return on equity of 1.90%. The company's ability to service its debt is also concerning, as indicated by a poor EBIT to interest ratio of 0.14.<BR><BR>Moreover, the stock's moving averages indicate that it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day averages, further suggesting a bearish trend. Despite a rise in investor participation, with delivery volume increasing by 156.29% on January 16, the overall sentiment remains negative due to the company's declining profitability and significant losses in the past year.